Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.
about
Epigenetic assays for chemical biology and drug discovery.Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.
P2860
Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging therapeutic targets i ...... y for various patient subsets.
@en
type
label
Emerging therapeutic targets i ...... y for various patient subsets.
@en
prefLabel
Emerging therapeutic targets i ...... y for various patient subsets.
@en
P2093
P2860
P1476
Emerging therapeutic targets i ...... y for various patient subsets.
@en
P2093
Håkon Reikvam
Tuyen Thi van Hoang
Øystein Bruserud
P2860
P304
P356
10.1586/17474086.2015.1036025
P577
2015-04-22T00:00:00Z